Healthcare Marketing Blogs
03|20|25
SXSW 2025: A Mandate, A Path, A Tool
At SXSW 2025, we heard loud and clear: Pharma marketers are facing the biggest challenge of our careers. But it's also the most rewarding challenge, and one that has sharpened our superpowers .In this POV, we discuss how we can harness these opportunities to navigate the challenges ahead.
03|18|25
The Digital Determinants of Health: Shaping the Future of Well-Being
Download the POV, The Digital Determinants of Health, to discover how understanding digital determinants of health can transform pharmaceutical strategies and drive business success.
03|13|25
AI With A Human Touch: Ensuring Authenticity in AI Marketing
In this POV, Morgan Hartzell, VP, Client Services, explores several key strategies to ensure marketing remains genuine and trustworthy, while still leveraging the benefits of AI technology.
03|07|25
Redefining Loyalty: The Role of Decentralized Healthcare and Data Ownership
This POV explores how decentralized healthcare models and data ownership are transforming patient loyalty, and highlights strategies to foster loyalty in this new landscape. Download the POV to learn more.
02|28|25
Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave
Learn the key takeaways and insights from a recent Med Ad News article about how to make a difference in rare disease marketing with creativity, data and innovation.
02|25|25
Bringing Creative Excellence to Pre-Flight Safety Videos: Insights From Ivan Blotta
EVERSANA INTOUCH's Head of Art and Creative Excellence shares three key elements that bring creative excellence into pharma marketing.
02|10|25
Next-Generation Brand Planning: (Unexpected) Worrying Trends Demand a Rethink on Brand Planning
In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning. Download the POV to learn more.
01|30|25
The Power of Data and Machine Learning to Optimize HCP Prescription Volume
In a recently published article from Med Ad News, co-authors Iyiola Obayomi, SVP, Managing Director, Data & Analytics, at EVERSANA INTOUCH, and Pierantonio Russo, MD, FCPP, FAAP, STS, Chief Medical Officer at EVERSANA, discuss the power of data and analytics and machine learning (ML) to optimize HCP targeting and prescription volume.
01|24|25
Creating Award-Winning Work: Insights From Susan Perlbachs With Muse by Clios
In a recent interview with Muse by Clios, Susan Perlbachs, Chief Creative Officer, offered profound insights into the ever-changing world of healthcare advertising. Dive into our blog to discover the secrets behind creating award-winning campaigns and explore inspiring examples.
01|21|25
2025 Data Privacy Landscape: Is Pharma Ready for the Scrutiny?
The data privacy landscape in 2025 presents new risks for pharmaceutical companies due to a surge in state-specific privacy laws in the U.S., evolving global regulations and increased scrutiny of artificial intelligence (AI) technologies. Today, compliance is essential for maintaining consumer trust, protecting sensitive health data and avoiding regulatory penalties. Access the POV to learn how your brand can prepare for the changes in the 2025 data privacy landscape.